申请人:WAYNE STATE UNIVERSITY
公开号:US10874669B2
公开(公告)日:2020-12-29
A compound having formula IA is useful for treating a neurodegenerative disease:
or a pharmaceutically acceptable salt or ester thereof, where R0, R1, R2, R7, R8 are delineated substituents; A1 is a C6-12 aryl group, C5-12 heteroaryl group, substituted 3-hydroxypyridin-4(1H)-one,
with i hydrogen atoms replaced with R7 and j hydrogen atoms replaced with R8; p is an integer from 1 to 6; X1, Y1 are each independently CH or N; M is absent or a divalent linking moiety in which Z is repeated m times; m is an integer from 0 to 5; i, j are each independently 0, 1, 2, or 3; and o is 0, 1, 2, 3, or 4.
具有式 IA 的化合物可用于治疗神经退行性疾病: 或其药学上可接受的盐或酯,其中 R0、R1、R2、R7、R8 是划定的取代基;A1 是 C6-12 芳基、C5-12 杂芳基、取代的 3-羟基吡啶-4(1H)-酮,其中 i 个氢原子被 R7 取代,j 个氢原子被 R8 取代; p 为 1-6 的整数;X1、Y1 各自独立地为 CH 或 N;M 不存在或为二价连接基团,其中 Z 重复 m 次;m 为 0-5 的整数;i、j 各自独立地为 0、1、2 或 3;以及 o 为 0、1、2、3 或 4。